Skip to main content
Data show positive results for Cardiovascular Systems' DiamondBack 360 system

Results from a trial presented at the annual Amputation Prevention Symposium showed use of peripheral interventions, including Cardiovascular Systems' DiamondBack 360 coronary orbital atherectomy system, for treating patients with critical limb ischemia demonstrated an 81.7% rate of freedom from amputation for Rutherford Classification 6 and 96% for RCs ranging from 4 to 5 at one year. A sub-analysis also showed that at 12 months, vessel preparation using the Diamondback led to a 95.2% rate of freedom from major adverse events without major amputations.

Full Story: